GUTS
Fractyl Health, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$114.85M
P/E Ratio
—
EPS
$-1.31
Beta
2.34
52W High
$2.44
52W Low
$0.38
50-Day MA
$0.69
200-Day MA
$1.10
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Fractyl Health, Inc. Common Stock
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company is headquartered in Lexington, Massachusetts.
Fundamentals
| Revenue (TTM) | 3,000 |
| Gross Profit (TTM) | 3,000 |
| EBITDA | $-91.76M |
| Operating Margin | 0.00% |
| Return on Equity | -778.00% |
| Return on Assets | -63.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | 5.37 |
| Price-to-Sales (TTM) | 7575.74 |
| EV/Revenue | 16846.11 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -57.10% |
| Shares Outstanding | $158.65M |
| Float | $143.45M |
| % Insiders | 1.31% |
| % Institutions | 52.47% |
Historical Volatility
HV 10-Day
127.62%
HV 20-Day
111.67%
HV 30-Day
123.70%
HV 60-Day
103.77%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($5.24 target)
5
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026